Principal Financial Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-456,180
Closed -$1.82M 2280
2019
Q4
$1.82M Buy
456,180
+1,630
+0.4% +$7.66K ﹤0.01% 1741
2019
Q3
$2.23M Sell
454,550
-855
-0.2% -$4.78K ﹤0.01% 1702
2019
Q2
$2.77M Buy
455,405
+568
+0.1% +$3.02K ﹤0.01% 1670
2019
Q1
$2.64M Sell
454,837
-4,685
-1% -$48.4K ﹤0.01% 1694
2018
Q4
$6.18M Sell
459,522
-12,637
-3% -$213K 0.01% 1425
2018
Q3
$9.16M Buy
472,159
+85,299
+22% +$1.82M 0.01% 1373
2018
Q2
$9.89M Buy
386,860
+17,837
+5% +$416K 0.01% 1314
2018
Q1
$7.44M Buy
369,023
+8,258
+2% +$193K 0.01% 1398
2017
Q4
$7.24M Buy
360,765
+197
+0.1% +$3.87K 0.01% 1426
2017
Q3
$7.47M Buy
360,568
+28,343
+9% +$479K 0.01% 1408
2017
Q2
$4.92M Buy
332,225
+2,372
+0.7% +$39.5K ﹤0.01% 1557
2017
Q1
$5.26M Buy
329,853
+15,576
+5% +$225K 0.01% 1513
2016
Q4
$3.96M Sell
314,277
-7,984
-2% -$149K 0.01% 1590
2016
Q3
$9.03M Buy
322,261
+60,797
+23% +$2.04M 0.01% 1179
2016
Q2
$9.15M Buy
261,464
+19,056
+8% +$599K 0.01% 1114
2016
Q1
$6.64M Buy
+242,408
New +$7.14M 0.01% 1240
2015
Q3
Sell
-5,454
Closed -$244K 2234
2015
Q2
$244K Buy
+5,454
New +$205K ﹤0.01% 1995

Other funds holding DPLO

Principal Financial Group's DPLO Position: Q1 2020 in Review

Principal Financial Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 456,180 shares — an estimated $1.82M sold.

Principal Financial Group first reported a position in DPLO in Q2 2015 and held it in 17 quarters. The position peaked at $9.89M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Principal Financial Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Principal Financial Group sold 456,180 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.82M.
  • Principal Financial Group first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 17 quarters.
  • Principal Financial Group's DIPLOMAT PHARMACY, INC. position peaked at $9.89M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Principal Financial Group's 13F filing for Q1 2020, filed 12 May 2020.